ABT – abbott laboratories (US:NYSE)

Butter Shortage on the Rise, Plus 13 Other Hard-to-Find Grocery Items [CNET News]

Don't get fooled again, Biden's baby formula crisis is far from over and still hitting our states hard [FOX News]

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm’s Attorneys, Deadline Approaching in Securities Fraud Class Action

Wellness is at the forefront of Active Aging Week in 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abbott Laboratories - ABT

ABBOTT LABORATORIES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Abbott Laboratories - ABT

ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action – ABT

CLASS ACTION UPDATE for ABT, SMFR and FLGT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

ABT SHAREHOLDER ALERT: Jakubowitz Law Reminds Abbott Shareholders of a Lead Plaintiff Deadline of October 31, 2022

ABBOTT LABORATORIES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Abbott Laboratories - ABT

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Abbott Laboratories To Contact Him Directly To Discuss Their Options

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm’s Attorneys, Deadline Approaching in Securities Fraud Class Action

Baby formula shortage: FDA response report cites outdated system, training issues [FOX News]

Baby formula shortage: FDA response report cites outdated system, training issues [FOX News]

Parents remain frustrated by baby formula shortage, call on Biden admin to put more pressure on manufacturers [FOX News]

CLASS ACTION UPDATE for KSS, ABT and PLTR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

ABT LAWSUIT ALERT: Levi & Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming Deadline

FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Abbott Laboratories - ABT

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Abbott, TuSimple, Kohl’s, and Sema4 and Encourages Investors to Contact the Firm

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abbott Laboratories - ABT

Hematology Analyzers Market Reliable Business Data Analysis and Forecast by 2028 [MarketWatch]

Percutaneous Coronary Intervention Market Size, Share and Forecast till 2028 [MarketWatch]

Supermarket Shortages: 13 Items That May Be Harder to Find in the Grocery Store [CNET News]

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Abbott Laboratories of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 31, 2022 - (NYSE: ABT)

ABBOTT LABORATORIES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Abbott Laboratories – ABT